Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Journal of the American College of Cardiology
|
May 1, 1996
A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction
R C Becker, J M Gore, C Lambrew, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 21, 2009
Platelet functions beyond hemostasis
S S Smyth, R P McEver, A S Weyrich, et al.
Journal of Thrombosis and Thrombolysis
|
April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design
T J Povsic, M G Cohen, M Y Chan, et al.
Physical Review Letters
|
May 21, 2010
Viscous Rayleigh-Taylor instability experiments at high pressure and strain rate
Hye-Sook Park, K T Lorenz, R M Cavallo, et al.
American Heart Journal
|
January 8, 1999
A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators
R C Becker, S P Ball, P Eisenberg, et al.
Journal of the American College of Cardiology
|
April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial
C P Cannon, C H McCabe, T D Henry, et al.
The American Journal of Cardiology
|
April 4, 1998
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia
S Borzak, C P Cannon, P L Kraft, et al.
Journal of Clinical Pharmacology
|
March 27, 2014
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF
I G Girgis, M R Patel, G R Peters, et al.
Clinical Cardiology
|
September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council
F W Verheugt, R C Becker, M E Bertrand, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 8, 2005
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial
J H Alexander, H Yang, R C Becker, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Journal of the American College of Cardiology
|
May 1, 1996
A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction
R C Becker, J M Gore, C Lambrew, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 21, 2009
Platelet functions beyond hemostasis
S S Smyth, R P McEver, A S Weyrich, et al.
Journal of Thrombosis and Thrombolysis
|
April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial design
T J Povsic, M G Cohen, M Y Chan, et al.
Physical Review Letters
|
May 21, 2010
Viscous Rayleigh-Taylor instability experiments at high pressure and strain rate
Hye-Sook Park, K T Lorenz, R M Cavallo, et al.
American Heart Journal
|
January 8, 1999
A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators
R C Becker, S P Ball, P Eisenberg, et al.
Journal of the American College of Cardiology
|
April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial
C P Cannon, C H McCabe, T D Henry, et al.
The American Journal of Cardiology
|
April 4, 1998
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia
S Borzak, C P Cannon, P L Kraft, et al.
Journal of Clinical Pharmacology
|
March 27, 2014
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF
I G Girgis, M R Patel, G R Peters, et al.
Clinical Cardiology
|
September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council
F W Verheugt, R C Becker, M E Bertrand, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 8, 2005
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial
J H Alexander, H Yang, R C Becker, et al.
Page
of 15